| 臺大學術典藏 |
2022-03-04T03:55:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-03-04T03:52:50Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; SHANG-JU WU; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-03-04T03:51:18Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO; Tang, Jih-Luh; SHANG-JU WU; Chou, Wen-Chien; SZU-CHUN HSU; Ko, Bor-Sheng; Tien, Hwei-Fang |
| 臺大學術典藏 |
2021-11-21T23:19:44Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu Wen; Tsai, Xavier Cheng Hong; HSIN-AN HOU; Tien, Feng Ming; Liu, Jia Hau; WEN-CHIEN CHOU; BOR-SHENG KO; YU-WEN CHEN; CHIEN-CHIN LIN; Cheng, Chieh Lung; Lo, Min Yen; Lin, Yun Chu; Lu, Li Chun; SHANG-JU WU; SUNG-HSIN KUO; Hong, Ruey Long; TAI-CHUNG HUANG; MING YAO |
| 臺大學術典藏 |
2021-11-21T23:19:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng Ming; CHENG-HONG TSAI; Huang, Sheng Chuan; Liu, Jia Hau; Chen, Chien-Yuan; YUAN-YEH KUO; Chuang, Yi Kuang; Tseng, Mei Hsuan; Peng, Yen Ling; Liu, Ming Chih; CHIA-WEN LIU; Liao, Xiu Wen; LIANG-IN LIN; Wu, Yu Sin; Hou, Mei Fang; SHANG-JU WU; SZU-CHUN HSU; BOR-SHENG KO; WEN-CHIEN CHOU; MING YAO; HSIN-AN HOU; JIH-LUH TANG; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-08-15T00:07:56Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
SHANG-YI HUANG; Lin, Hsiu Hsia; MING YAO; JIH-LUH TANG; SHANG-JU WU; WEN-CHIEN CHOU; SZU-CHUN HSU; BOR-SHENG KO; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-05T00:56:44Z |
Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
|
Tseng M.-H.; Chiou R.-J.; Huang C.-F.; SHANG-JU WU; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Lin L.-I.; Yao M.; Tsay W.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Ko B.-S.; Tsay W.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan
|
SHANG-JU WU; Tien H.-F.; Wang C.-H.; Chen C.-Y.; Su I.-J.; Tang J.-L.; Chou W.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:41Z |
EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1and a worse prognosis
|
Liu T.-Y.; SHANG-JU WU; Huang M.-H.; Lo F.-Y.; Tsai M.-H.; Tsai C.-H.; Hsu S.-M.; Lin C.-W. |
| 臺大學術典藏 |
2021-01-05T00:56:41Z |
Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation
|
Yang Y.-C.; Lio H.-Y.; SHANG-JU WU; Wu J.; Tang J.-L. |
| 臺大學術典藏 |
2021-01-05T00:56:40Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Ko B.-S.; Huang S.-Y.; Yao M.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Tseng M.-H.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:39Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Lee F.-Y.; Kuo K.-T.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Liu M.-C.; Liu C.-W.; Tseng M.-H. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Kuo Y.-Y.; Chang Y.-C.; Chen Y.-C.; Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Tsay W.; Yao M.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; Tang J.-L.; Tien H.-F.; Huang C.-F.; Tseng M.-H.; Liu C.-W.; Kuo K.-T.; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Lin C.-W.; Jhuang J.-Y.; Hou H.-A.; Cheng C.-L.; Tien H.-F.; Chen Y.-C.; Tsay W.; Chen C.-Y.; Tang J.-L.; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU |
| 臺大學術典藏 |
2021-01-05T00:56:38Z |
Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis
|
Wu S.-G.; Tsai T.-H.; SHANG-JU WU |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Huang S.-Y.; Yao M.; Chou W.-C.; Chen C.-Y.; Lin C.-T.; Liu C.-W.; Liu M.-C.; SHANG-JU WU; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Ko B.-S.; Tang J.-L.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Kuo Y.-Y.; Hou H.-A.; Ko B.-S.; Huang S.-Y.; Yao M.; Tang J.-L.; Liu C.-W.; Liu M.-C.; Lee F.-Y.; Chiang Y.-C.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Hsu S.-C.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
Improving but Inferior Survival in Patients with Chronic Lymphocytic Leukemia in Taiwan: A Population-Based Study, 1990-2004
|
Lin C.-T.; Chiang C.-J.; SHANG-JU WU; Tien H.-F.; Lai M.-S. |
| 臺大學術典藏 |
2021-01-05T00:56:37Z |
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
|
Chen H.-Y.; Lin C.-W.; Lai Y.-J.; Jhuang J.-Y.; Liu C.-Y.; Lee M.-C.; Cheng C.-L.; Hou H.-A.; Tien H.-F.; Liu F.-T.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W. |
| 臺大學術典藏 |
2021-01-05T00:56:36Z |
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the East
|
Huang S.-Y.; Lin C.-T.; SHANG-JU WU; Tien H.-F.; Tsay W.; Tang J.-L.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Yao M. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Tsay W.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; SHANG-JU WU; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Tseng M.-H.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; SHANG-JU WU; Liu C.-Y.; Chen C.-Y.; Tsay W.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Hsu S.-C.; Ko B.-S.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:35Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Chen C.-Y.; Ko B.-S.; Huang S.-Y.; Kuo Y.-Y.; Li C.-C.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Hsu S.-C.; Lin C.-T.; SHANG-JU WU; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:34Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lee F.-Y.; Chiang Y.-C.; Huang C.-F.; Tseng M.-H.; Lai Y.-J.; Chen C.-Y.; Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tien H.-F.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SHANG-JU WU; Tsay W.; Chen Y.-C. |
